Supply of Lonza 4D-Nucleofector Core Unit (CLIN 1)

The contract seeks the procurement and delivery of a Lonza 4D-Nucleofector Core Unit or an equivalent system designed for the efficient transfection of DNA, RNA, and proteins into a wide range of cell lines and primary cells. The equipment must feature metal-free electrodes to ensure compatibility with sensitive biological samples and deliver high cell viability post-transfection, which is critical for downstream research and clinical applications. The device is intended for use in a regulated environment where reproducibility, safety, and performance are paramount. This is a subcontract under the FDA Office of Acquisition and Grant Services, part of the Department of Health and Human Services, with a North American Industry Classification System code of 334516 indicating medical equipment manufacturing. The solicitation was posted on July 26, 2026, and responses are due by August 3, 2026. There is no set-aside designation, and the place of performance is not specified, though the system must meet exact technical requirements for laboratory use. All bids must comply with the stated functional specifications without deviation to ensure uniformity and reliability in experimental outcomes.